投资全球更要投资自己
我的订阅

On innovative drug shares: favorable new listing policies main catalysts

作者: 张涓义

Pharm stocks have gained great market attention recently, buoyed by a rise in both valuations and public funds’ holdings. With favorable tailwind policies for biotech IPOs in mainland China and HK, innovative drug stocks are expected to embrace an even stronger rally in 2Q18

写评论

icon-emoji表情
图片